Abstract
Delivering exogenous DNA or genes directly to the lung airways offers a unique and appealing opportunity for specifically targeting gene expression to airway and alveolar epithelium. A large body of literature and experience supports the feasibility of this approach. However, airway-directed gene delivery is not as simple as was originally anticipated. The lung has evolved both physical and immunologic barriers that can hinder effective transduction of epithelial cells (1–3). Much current work in lung gene therapy is directed toward overcoming the inflammatory and immune responses provoked by gene-transfer vectors while simultaneously maximizing vector delivery and subsequent gene expression.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Otake, K., Ennist, D. L., Harrod, K., and Trapnell, B. C. (1998) Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum. Gene. Ther. 9, 2207–2222.
Look, D. C. and S. L. Brody (1999) Engineering viral vectors to subvert the airway defense response. Am. J. Respir. Cell Mol. Biol. 20, 1103–1106.
Bromberg, J. S., Debruyne, L. A., and Qin, L. (1998) Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression. Adv. Immunol. 69, 353–409.
Factor, P. (2001) Gene therapy for acute diseases. Mol. Ther. 4, 515–524.
Jobe, A. H., Ueda, T., Whitsett, J. A., Trapnell, B. C., and Ikegami, M. (1996) Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther. 3, 775–779.
Katkin, J. P., Husser, R. C., Langston, C., and Welty, S. E. (1997) Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum. Gene. Ther. 8, 171–176.
Factor, P., Saldias, F., Ridge, K., Dumasius, V., Zabner, J. H., Jaffe, A., et al. (1998) Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na, K-ATPase betal subunity gene. J. Clin. Invest. 102, 1421–1430.
Weiss, D. J., Strandjord, T. P., Jackson, J. C., Clark, J. G., and Liggitt, D. (1999) Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. Exp. Lung Res. 25, 317–333.
Weiss, D. J., Strandjord, T. P., Liggitt, D., and Clark, J. G. (1999) Perflubron enhances adenoviral-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum. Gene. Ther. 10, 2287–2293.
Wang, G., Zabner, J., Deering, C., Launspach, J. Shao, J., Bodner, M., Jolly, D. J. et al. (2000) Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am. J. Respir. Cell Mol. Biol. 22, 129–138.
Chu, Q., St. George, J. A., Lukason, M., Cheng, S. H., Scheule, R. K., and Eastman, S. J. (2001) EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum. Gene. Ther. 12, 455–467.
Fasbender, A., Lee, J. H., Walters, R. W., Moninger, T. O., Zabner, J., and Welsh, M. J. (1998) Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J. Clin. Invest. 102, 184–193.
Parsons, D. W., Grubb, B. R., Johnson, L. G., and Boucher, R. C. (1998) Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum. Gene. Ther. 9, 2661–2672.
Marshall, D. J, Palasis, M., Lepore, J. J., and Leiden, J. M. (2000) Biocompatability of cardiovascular gene delivery catheters with adenovirus vectors: an important determinant of the efficiency of cardiovascular gene transfer. Mol. Ther. 1, 423–429.
Tsui, L. V., Zayek, N., Frey, D., Mello, C., Banik, G., Falotico, R., and McArthur, J. G. (2001) Stability of adenoviral vectors following catheter delivery. Mol. Ther. 3, 122–125.
Harvey, B. G., Leopold, P. L., Hackett, N. R., Grasso, T. M., Williams, P. M., Tucker, A. L., et al. (1999) Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 104, 1165–1166.
Lisby, D. A., Ballard, P. L., Fox, W. W., Wolfson, M. R., Shaffer, T. H., and Gonzales, L. W. (1997) Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid. Hum. Gene. Ther. 8, 919–928.
Weiss, D. J., Bonneau, L., and Liggitt, D. (2001) Use of perfluorochemical liquid allows earlier detection and use of less adenovirus vector for gene expression in normal lung and enhances gene expression in acutely injured lung. Mol. Ther. 3, 734–745.
Weiss, D. J., Baskin, G. B., Shean, M. K., Blanchard, J. L., and Kolls, J. K. (2002) Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates. Mol. Ther. 5, 8–15.
Franz, A. R., Rohlke, W., Franke, R. P., Ebsen, M., Pohlandt, F., and Hummler, H. D. (2001) Pulmonary administration of perfluorodecaline-gentamycin and perfluorodecaline-vancomycin emulsions (2001). Am. J. Resp. Crit. Care Med. 164, 1595–1600.
Weiss, D. J., Mutlu, G. M., Bonneau, L., Mendez, M., Wang, Y., Dumasius, V., and Factor, P. (2002) Comparison of surfactant and perfluorochemical liquid enhanced adenovirus-mediated gene transfer in normal rat lung. Mol. Ther. 6, 43–49.
Spragg, R. G. (2001) Surfactant replacement therapy. Clin. Chest Med. 21, 531–541.
Sene, C., Bout, A., Imler, J. L., Schultz, H., Willemot, J. M., Hennebel, V., et al. (1995) Aerosol-mediated delivery of recombinant adenovirus to the airways of non-human primates. Hum. Gene. Ther. 6, 1587–1593.
Katkin, J. P., Gilbert, B. E., Langston, C., French, K., and Beaudet, A. L. (1995) Aerosol delivery of β-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene. Ther. 6, 985–995.
Bellon, G., Michel-Calemard, L., Thouvenot, D., Jagneaux, V., Poitevin, F., et al. (1997) Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum. Gene. Ther. 8, 15–25.
McDonald, R. J., Lukason, M. J., Raabe, O. G., Canfield, D. R., Burr, E. A., et al. (1997) Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum.Gene.Ther. 8,411–422.
Muir, D. F. C. (1991) Particle deposition, in The Lung: Scientific Foundations (Crystal, R.G., ed.), Raven Press Ltd., New York, NY, pp. 1839–1843.
van Heeckeren, A., Ferkol, T., and Tosi, M. (1998) Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther. 5, 345–351.
Stern, M., Caplen, N. J., Browning, J. E., Griesenbach, U., Sorgi, F., Huang, L., et al. (1998) The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 5, 91–98.
Kitson, C., Angel, B., Judd, D., Rothery, S., Severs, N. J., Dewar, A., et al. (1998) The extra-and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 6, 534–546.
Factor, P., Mendez, M., Mutlu, G. M., and Dumasius, V. (2002) Acute hyperoxic lung injury does not impede adenovirual-mediated alveolar gene transfer. Am. J. Resp. Crit. Care Med. 165, 521–526.
Kossila M., Jauhianen, S., Laukkanen, M. O., Lehtolainen, P., Jaaskelainen, M., Turunen, P., et al. (2002) Improvement in adenoviral gene transfer efficiency after pre-incubation at 37°C in vitro and in vivo. Mol. Ther. 5, 87–93.
Nyberg-Hoffman, C. and Aguilar-Cordova, E. (1999) Instability of adenoviral vectors during transport and its implication for clinical studies. Nature Med. 5, 955–957.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.,Totowa ,NJ
About this protocol
Cite this protocol
Weiss, D.J. (2004). Delivery of DNA to Lung Airway Epithelium. In: Heiser, W.C. (eds) Gene Delivery to Mammalian Cells. Methods in Molecular Biology™, vol 246. Humana Press. https://doi.org/10.1385/1-59259-650-9:53
Download citation
DOI: https://doi.org/10.1385/1-59259-650-9:53
Publisher Name: Humana Press
Print ISBN: 978-1-58829-095-3
Online ISBN: 978-1-59259-650-8
eBook Packages: Springer Protocols